Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 1/2021

01-02-2021 | Pancreatitis | Research Article

Dose–response of intravenous calcium in the surgical intensive care unit

Authors: Christopher Alan Giuliano, Vitaliy Perets, Mariam Hijazi, Joseph R. Buck, Renee A. Paxton

Published in: International Journal of Clinical Pharmacy | Issue 1/2021

Login to get access

Abstract

Background Hypocalcemia is common in patients admitted to the surgical intensive care unit and is associated with increased morbidity and mortality. Current dosing strategies do not always achieve ionized calcium (iCa) normalization, especially in patients with severe hypocalcemia. Objective The purpose of this study was to explore the association between intravenous (IV) calcium dose and change in ionized calcium. Setting Patients admitted to the surgical intensive care unit with concomitant hypocalcemia at a large academic hospital in the United States. Method This single center, retrospective cohort study evaluated the association between IV calcium dose and subsequent change in ionized calcium level in adult surgical intensive care unit patients with hypocalcemia. The primary outcome of this study was to develop a model exploring the association between IV calcium dose and change in iCa levels. Secondary outcomes included describing the average IV calcium dose required to normalize iCa levels, average time to normalization of iCa levels, and assessing the safety of IV calcium replacement. Main outcome measure Change in iCa. Results One hundred and ninety-four patients met study criteria. In the final model initial iCa level, total calcium dose, the interaction between initial iCa level and total calcium dose, age, and pancreatitis remained. The model (R2 = 0.625) is expressed by the following equation: Change in iCa level = 0.462 − 0.011 × [Ca dose] − 0.0007 × [Age] − 0.259 × [Initial iCa] + 0.076 × [initial iCa × Ca dose] − 0.076 × [Pancreatitis]. Removing two patients that received > 10 grams of total calcium improved the R2 to 0.769. Lastly, a simplified model removing age and pancreatitis found a similar R2 of 0.756. Conclusion We observed that change in iCa level after initial calcium dose depended on the baseline iCa. Our full and simplified model excluding two outliers predicted 76.9% and 75.6% of the variation in iCa response, respectively. If validated in other settings this model could be utilized to provide more accurate calcium dosing.
Literature
1.
go back to reference Zivin JR, Gooley T, Zager RA, Ryan MJ. Hypocalcemia: a pervasive metabolic abnormality in the critically ill. Am J Kidney Dis. 2001;37:689–98.CrossRef Zivin JR, Gooley T, Zager RA, Ryan MJ. Hypocalcemia: a pervasive metabolic abnormality in the critically ill. Am J Kidney Dis. 2001;37:689–98.CrossRef
2.
go back to reference Zaloga GP. Hypocalcemia in critically ill patients. Crit Care Med. 1992;20:251–62.CrossRef Zaloga GP. Hypocalcemia in critically ill patients. Crit Care Med. 1992;20:251–62.CrossRef
3.
go back to reference Chernow B, Zaloga G, McFadden E, Clapper M, Kotler M, Barton M, et al. Hypocalcemia in critically ill patients. Crit Care Med. 1982;10:848–51.CrossRef Chernow B, Zaloga G, McFadden E, Clapper M, Kotler M, Barton M, et al. Hypocalcemia in critically ill patients. Crit Care Med. 1982;10:848–51.CrossRef
4.
go back to reference Desai TK, Carlson RW, Geheb MA. Prevalence and clinical implications of hypocalcemia in acutely III patients in a medical intensive care setting. Am J Med. 1988;84:209–14.CrossRef Desai TK, Carlson RW, Geheb MA. Prevalence and clinical implications of hypocalcemia in acutely III patients in a medical intensive care setting. Am J Med. 1988;84:209–14.CrossRef
5.
go back to reference Burchard KW, Gann DS, Colliton J, Forster J. Ionized calcium, parathormone, and mortality in critically ill surgical patients. Ann Surg. 1990;212:543–50.CrossRef Burchard KW, Gann DS, Colliton J, Forster J. Ionized calcium, parathormone, and mortality in critically ill surgical patients. Ann Surg. 1990;212:543–50.CrossRef
6.
go back to reference Steele T, Kolamunnage-Dona R, Downey C, Toh CH, Welters I. Assessment and clinical course of hypocalcemia in critical illness. Crit Care. 2013;17:R106.CrossRef Steele T, Kolamunnage-Dona R, Downey C, Toh CH, Welters I. Assessment and clinical course of hypocalcemia in critical illness. Crit Care. 2013;17:R106.CrossRef
7.
go back to reference Kelly A, Levine MA. Hypocalcemia in the critically ill patient. J Intensive Care Med. 2013;28:166–77.CrossRef Kelly A, Levine MA. Hypocalcemia in the critically ill patient. J Intensive Care Med. 2013;28:166–77.CrossRef
8.
go back to reference Giancarelli A, Birrer KL, Alban RF, Hobbs BP, Liu-Deryke X. Hypocalcemia in trauma patients receiving massive transfusion. J Surg Res. 2016;202:182–7.CrossRef Giancarelli A, Birrer KL, Alban RF, Hobbs BP, Liu-Deryke X. Hypocalcemia in trauma patients receiving massive transfusion. J Surg Res. 2016;202:182–7.CrossRef
9.
go back to reference Forsythe RM, Wessel CB, Billiar TR, Angus DC, Rosengart MR. Parenteral calcium for intensive care unit patients. Cochrane Database Syst Rev. 2008;4:CD006163. Forsythe RM, Wessel CB, Billiar TR, Angus DC, Rosengart MR. Parenteral calcium for intensive care unit patients. Cochrane Database Syst Rev. 2008;4:CD006163.
10.
go back to reference Dickerson RN, Morgan LM, Cauthen AD, Alexander KH, Croce MA, Minard G, et al. Treatment of acute hypocalcemia in critically III multiple-trauma patients. J Parenter Enteral Nutr. 2005;29:436–41.CrossRef Dickerson RN, Morgan LM, Cauthen AD, Alexander KH, Croce MA, Minard G, et al. Treatment of acute hypocalcemia in critically III multiple-trauma patients. J Parenter Enteral Nutr. 2005;29:436–41.CrossRef
11.
go back to reference Dickerson RN, Morgan LM, Croce MA, Minard G, Brown RO. Dose-dependent characteristics of intravenous calcium therapy for hypocalcemic critically ill trauma patients receiving specialized nutritional support. Nutrition. 2007;23:9–15.CrossRef Dickerson RN, Morgan LM, Croce MA, Minard G, Brown RO. Dose-dependent characteristics of intravenous calcium therapy for hypocalcemic critically ill trauma patients receiving specialized nutritional support. Nutrition. 2007;23:9–15.CrossRef
12.
go back to reference Dzik WH, Kirkley SA. Citrate toxicity during massive blood transfusion. Transfus Med Rev. 1988;2:76–94.CrossRef Dzik WH, Kirkley SA. Citrate toxicity during massive blood transfusion. Transfus Med Rev. 1988;2:76–94.CrossRef
Metadata
Title
Dose–response of intravenous calcium in the surgical intensive care unit
Authors
Christopher Alan Giuliano
Vitaliy Perets
Mariam Hijazi
Joseph R. Buck
Renee A. Paxton
Publication date
01-02-2021
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 1/2021
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-020-01145-7

Other articles of this Issue 1/2021

International Journal of Clinical Pharmacy 1/2021 Go to the issue

ACKNOWLEDGEMENT

Thank You Reviewers